Cas no 88321-09-9 (Aloxistatin)

Aloxistatin structure
Aloxistatin structure
Product Name:Aloxistatin
CAS No:88321-09-9
MF:C17H30N2O5
MW:342.430505275726
MDL:MFCD00132883
CID:722115
PubChem ID:24894681
Update Time:2024-10-26

Aloxistatin Chemical and Physical Properties

Names and Identifiers

    • 2-Oxiranecarboxylicacid,3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-,ethyl ester, (2S,3S)-
    • E-64d [for Biochemical Research]
    • E-64d
    • (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]-butyl]amino]carbonyl]-2-oxiranecarboxylic acid ethyl ester
    • 2-Oxiranecarboxylicacid,3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbo...
    • ALLATOSTATIN I
    • Aloxistatin
    • E 64d
    • E-64-d
    • E-64d (EST,EP 453,NSC 694281, Aloxistatin)
    • EST
    • L-trans-Epoxysuccinyl-Leu-3-methylbutylamide-ethyl ester
    • Aloxistatin (E-64d) EST Loxistatin
    • E64c ethyl ester
    • ep453
    • LOXASTATIN
    • LOXISTATIN
    • (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester
    • Ethyl (2S,3S)-3-[[(2S)-4-Methyl-1-[(3-methylbutyl)amino]-1-oxo-2-pentanyl]carbamoyl]-2-oxiranecarboxylate
    • (2S,3S)-3-[[(2S)-4-Methyl-1-[(3-methylbutyl)amino]-1-oxo-2-pentanyl]carbamoyl]-2-oxiranecarboxylic Acid Ethyl Ester
    • Aloxistatine
    • Aloxistatinum
    • Aloxistatina
    • Aloxistatin [INN]
    • E 64c ethyl ester
    • EST (pharmaceutical)
    • Aloxistatine [French]
    • Aloxistatinum [Latin]
    • Aloxistatina [Spanish]
    • C17H30N2O5
    • EP 453
    • E64d
    • L5W337AOUR
    • MLS000028372
    • SMR000058552
    • Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate
    • Oxiranecarb
    • Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)- (9CI)
    • Oxiranecarboxylic acid, 3-[[[3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, [2S-[2α,3β(R*)]]- (ZCI)
    • E64d/pepstatin
    • NSC 694281
    • Pepstatin E64d
    • MDL: MFCD00132883
    • Inchi: 1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1
    • InChI Key: SRVFFFJZQVENJC-IHRRRGAJSA-N
    • SMILES: C([C@H]1O[C@@H]1C(=O)OCC)(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C
    • BRN: 5354546

Computed Properties

  • Exact Mass: 342.21500
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 5
  • Heavy Atom Count: 24
  • Rotatable Bond Count: 11
  • Complexity: 450
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 2
  • Undefined Atom Stereocenter Count : 1
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.3
  • Topological Polar Surface Area: 97
  • Surface Charge: 0
  • Tautomer Count: 4

Experimental Properties

  • Color/Form: solid
  • Density: 1.0657 (rough estimate)
  • Melting Point: 126°C(lit.)
  • Boiling Point: 538°C at 760 mmHg
  • Refractive Index: 1.5800 (estimate)
  • Solubility: Soluble in DMSO, DMF or ethanol
  • PSA: 97.03000
  • LogP: 1.79190
  • Solubility: Not determined

Aloxistatin Security Information

  • Signal Word:Warning
  • Hazard Statement: H315-H319-H335
  • Warning Statement: P261-P305+P351+P338
  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:2
  • Hazard Category Code: 36/37/38
  • Safety Instruction: 26-36
  • RTECS:RR0404300
  • Hazardous Material Identification: Xi
  • Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
  • Risk Phrases:R36/37/38

Aloxistatin Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
E1337-25MG
Aloxistatin
88321-09-9 >95.0%(HPLC)
25MG
¥3,990.00 2021-05-19
SHANG HAI XIAN DING Biotechnology Co., Ltd.
E1337-5MG
Aloxistatin
88321-09-9 95.0%(LC)
5MG
1290CNY 2021-05-07
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-TP582-5mg
Aloxistatin
88321-09-9 98%
5mg
1395CNY 2021-05-07
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-TP582-1mg
Aloxistatin
88321-09-9 98%
1mg
634CNY 2021-05-07
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-TP582-10mg
Aloxistatin
88321-09-9 98%
10mg
2541CNY 2021-05-07
MedChemExpress
HY-100229-10mM*1mLinDMSO
Aloxistatin
88321-09-9 99.55%
10mM*1mLinDMSO
¥829 2022-05-30
MedChemExpress
HY-100229-5mg
Aloxistatin
88321-09-9 99.55%
5mg
¥1100 2025-04-15
MedChemExpress
HY-100229-10mg
Aloxistatin
88321-09-9 99.55%
10mg
¥1900 2025-04-15
MedChemExpress
HY-100229-25mg
Aloxistatin
88321-09-9 99.55%
25mg
¥3040 2025-04-15
MedChemExpress
HY-100229-50mg
Aloxistatin
88321-09-9 99.55%
50mg
¥4250 2025-04-15

Aloxistatin Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Potassium hydroxide Solvents: Water ;  2 h, 0 °C
Reference
Stereoselective synthesis of the epoxysuccinyl peptide E-64c
Lygo, Barry; et al, Synlett, 2006, (13), 2063-2066

Production Method 2

Reaction Conditions
1.1 Reagents: Dicyclohexylcarbodiimide ,  1-Hydroxybenzotriazole Solvents: Ethyl acetate ;  3 h, 0 °C; 12 h, rt
Reference
Design, synthesis, and screen of cathepsin K inhibitors
Yu, Ying-Ying; et al, Chinese Chemical Letters, 2013, 24(8), 715-718

Production Method 3

Reaction Conditions
1.1 Reagents: Dicyclohexylcarbodiimide Solvents: Ethyl acetate
2.1 Solvents: Ethyl acetate
Reference
An efficient synthetic method for ethyl (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases
Tamai, Masaharu; et al, Chemical & Pharmaceutical Bulletin, 1987, 35(3), 1098-104

Production Method 4

Reaction Conditions
1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol ,  Ethyl acetate
2.1 Reagents: 4-Methylmorpholine ,  1-Hydroxybenzotriazole ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Chloroform
2.2 Solvents: Ethyl acetate ,  Water
Reference
A new synthesis of peptidyl epoxysuccinates for probing cysteine protease-inhibitor P3/S3 binding interactions
Roush, William R.; et al, Synthesis, 1999, 1500, 1500-1504

Production Method 5

Reaction Conditions
1.1 Reagents: Hydrochloric acid Solvents: Ethyl acetate
2.1 Solvents: Ethyl acetate
Reference
An efficient synthetic method for ethyl (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases
Tamai, Masaharu; et al, Chemical & Pharmaceutical Bulletin, 1987, 35(3), 1098-104

Production Method 6

Reaction Conditions
1.1 Reagents: 1-Hydroxybenzotriazole ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Dichloromethane ,  4-Methylmorpholine
2.1 Reagents: m-Chloroperbenzoic acid Solvents: Chloroform ;  50 °C
3.1 Reagents: Potassium hydroxide Solvents: Water ;  2 h, 0 °C
Reference
Stereoselective synthesis of the epoxysuccinyl peptide E-64c
Lygo, Barry; et al, Synlett, 2006, (13), 2063-2066

Production Method 7

Reaction Conditions
1.1 Reagents: 4-Methylmorpholine ,  1-Hydroxybenzotriazole ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Chloroform
1.2 Solvents: Ethyl acetate ,  Water
Reference
A new synthesis of peptidyl epoxysuccinates for probing cysteine protease-inhibitor P3/S3 binding interactions
Roush, William R.; et al, Synthesis, 1999, 1500, 1500-1504

Production Method 8

Reaction Conditions
1.1 Solvents: Ethyl acetate
Reference
An efficient synthetic method for ethyl (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases
Tamai, Masaharu; et al, Chemical & Pharmaceutical Bulletin, 1987, 35(3), 1098-104

Production Method 9

Reaction Conditions
1.1 Reagents: Lithium ethoxide Solvents: Ethanol ;  10 min, rt
1.2 Reagents: 4-(Dimethylamino)pyridine ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Dimethylformamide ;  4 h, rt
Reference
Stereoselective synthesis of E-64 and related cysteine proteases inhibitors from 2,3-epoxyamides
Sarabia, Francisco; et al, Bioorganic & Medicinal Chemistry, 2005, 13(5), 1691-1705

Production Method 10

Reaction Conditions
1.1 Reagents: Potassium hydroxide Solvents: Water ;  1 h, 4 °C → 6 °C; 4 h, rt
2.1 Reagents: Dicyclohexylcarbodiimide ,  1-Hydroxybenzotriazole Solvents: Ethyl acetate ;  3 h, 0 °C; 12 h, rt
Reference
Design, synthesis, and screen of cathepsin K inhibitors
Yu, Ying-Ying; et al, Chinese Chemical Letters, 2013, 24(8), 715-718

Production Method 11

Reaction Conditions
1.1 Reagents: Hydrochloric acid Solvents: Ethyl acetate ;  2.5 h, rt
2.1 Reagents: Dicyclohexylcarbodiimide ,  1-Hydroxybenzotriazole Solvents: Ethyl acetate ;  3 h, 0 °C; 12 h, rt
Reference
Design, synthesis, and screen of cathepsin K inhibitors
Yu, Ying-Ying; et al, Chinese Chemical Letters, 2013, 24(8), 715-718

Production Method 12

Reaction Conditions
1.1 Reagents: 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone Solvents: Benzene ;  72 h, reflux
2.1 Reagents: Lithium ethoxide Solvents: Ethanol ;  10 min, rt
2.2 Reagents: 4-(Dimethylamino)pyridine ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Dimethylformamide ;  4 h, rt
Reference
Stereoselective synthesis of E-64 and related cysteine proteases inhibitors from 2,3-epoxyamides
Sarabia, Francisco; et al, Bioorganic & Medicinal Chemistry, 2005, 13(5), 1691-1705

Production Method 13

Reaction Conditions
1.1 Reagents: m-Chloroperbenzoic acid Solvents: Chloroform ;  50 °C
2.1 Reagents: Potassium hydroxide Solvents: Water ;  2 h, 0 °C
Reference
Stereoselective synthesis of the epoxysuccinyl peptide E-64c
Lygo, Barry; et al, Synlett, 2006, (13), 2063-2066

Production Method 14

Reaction Conditions
1.1 Reagents: Dicyclohexylcarbodiimide ,  1-Hydroxybenzotriazole Solvents: Ethanol ;  1.5 h, 3 °C → 8 °C; 2.5 h, rt
2.1 Reagents: Hydrochloric acid Solvents: Ethyl acetate ;  2.5 h, rt
3.1 Reagents: Dicyclohexylcarbodiimide ,  1-Hydroxybenzotriazole Solvents: Ethyl acetate ;  3 h, 0 °C; 12 h, rt
Reference
Design, synthesis, and screen of cathepsin K inhibitors
Yu, Ying-Ying; et al, Chinese Chemical Letters, 2013, 24(8), 715-718

Production Method 15

Reaction Conditions
1.1 Reagents: Sulfuric acid ;  4.5 h, reflux
2.1 Reagents: Potassium hydroxide Solvents: Water ;  1 h, 4 °C → 6 °C; 4 h, rt
3.1 Reagents: Dicyclohexylcarbodiimide ,  1-Hydroxybenzotriazole Solvents: Ethyl acetate ;  3 h, 0 °C; 12 h, rt
Reference
Design, synthesis, and screen of cathepsin K inhibitors
Yu, Ying-Ying; et al, Chinese Chemical Letters, 2013, 24(8), 715-718

Production Method 16

Reaction Conditions
1.1 Reagents: 4-Methylmorpholine ,  1-Hydroxybenzotriazole ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Chloroform
1.2 Solvents: Ethyl acetate ,  Water
2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol ,  Ethyl acetate
3.1 Reagents: 4-Methylmorpholine ,  1-Hydroxybenzotriazole ,  1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride Solvents: Chloroform
3.2 Solvents: Ethyl acetate ,  Water
Reference
A new synthesis of peptidyl epoxysuccinates for probing cysteine protease-inhibitor P3/S3 binding interactions
Roush, William R.; et al, Synthesis, 1999, 1500, 1500-1504

Aloxistatin Raw materials

Aloxistatin Preparation Products

Aloxistatin Suppliers

Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
(CAS:88321-09-9)阿洛司他丁
Order Number:LE26719724
Stock Status:in Stock
Quantity:25KG,200KG,1000KG
Purity:99%
Pricing Information Last Updated:Friday, 20 June 2025 12:57
Price ($):discuss personally
Recommended suppliers
Tiancheng Chemical (Jiangsu) Co., Ltd
(CAS:88321-09-9)阿洛司他丁
LE26719724
Purity:99%
Quantity:25KG,200KG,1000KG
Price ($):Inquiry
Email